Literature DB >> 17052183

Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis.

K A Reedquist1, J Ludikhuize, P P Tak.   

Abstract

Although the mechanisms leading to the induction of RA (rheumatoid arthritis) are poorly understood, improper activation, proliferation, survival and retention of neutrophils, macrophages, lymphocytes and other leucocytes contribute to perpetuation of inflammation and eventual joint destruction through activation of stromal fibroblast-like synoviocytes. Fundamental studies in developmental biology, cellular biology and immunology have established critical roles for PI3K (phosphoinositide 3-kinase) signal transduction pathways in cellular chemotactic responses, proliferation, apoptosis and survival. Despite profound alteration of these cellular processes in RA, involvement of PI3K signalling pathways in this chronic inflammatory disease, and their assessment as potential therapeutic targets, has until recently received scant attention. This review highlights recent advances in our understanding of PI3K signalling pathways, in particular regulation of FoxO (forkhead box O) transcription factors, and their relevance to RA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052183     DOI: 10.1042/BST0340727

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  10 in total

Review 1.  Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis.

Authors:  Elaine Beaulieu; Eric F Morand
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

2.  Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway.

Authors:  Jing Tian; Jin-wei Chen; Jie-sheng Gao; Len Li; Xi Xie
Journal:  Rheumatol Int       Date:  2013-01-18       Impact factor: 2.631

3.  PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.

Authors:  Dalya R Soond; Elisa Bjørgo; Kristine Moltu; Verity Q Dale; Daniel T Patton; Knut Martin Torgersen; Fiona Galleway; Breda Twomey; Jonathan Clark; J S Hill Gaston; Kjetil Taskén; Peter Bunyard; Klaus Okkenhaug
Journal:  Blood       Date:  2010-01-15       Impact factor: 22.113

4.  FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.

Authors:  C T Karadedou; A R Gomes; J Chen; M Petkovic; K-K Ho; A K Zwolinska; A Feltes; S Y Wong; K Y K Chan; Y-N Cheung; J W H Tsang; J J Brosens; U-S Khoo; E W-F Lam
Journal:  Oncogene       Date:  2011-08-22       Impact factor: 9.867

Review 5.  The Role of Forkhead Box Family in Bone Metabolism and Diseases.

Authors:  Jianxiang Xu; Kanbin Wang; Zengjie Zhang; Deting Xue; Weixu Li; Zhijun Pan
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

6.  One of the active ingredients in Paeoniae Radix Alba functions as JAK1 inhibitor in rheumatoid arthritis.

Authors:  Lu Xiao; Shudian Lin; Feng Zhan
Journal:  Front Pharmacol       Date:  2022-09-19       Impact factor: 5.988

Review 7.  Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?

Authors:  Aleksander M Grabiec; Paul P Tak; Kris A Reedquist
Journal:  Arthritis Res Ther       Date:  2008-10-17       Impact factor: 5.156

8.  FOXO3a promotes gastric cancer cell migration and invasion through the induction of cathepsin L.

Authors:  Shan Yu; Yiyi Yu; Wen Zhang; Wei Yuan; Naiqing Zhao; Qian Li; Yuehong Cui; Yan Wang; Wei Li; Yihong Sun; Tianshu Liu
Journal:  Oncotarget       Date:  2016-06-07

9.  FOXM1 facilitates gastric cancer cell migration and invasion by inducing Cathepsin D.

Authors:  Li Yang; Ming Cui; Liang Zhang; Lei Song
Journal:  Oncotarget       Date:  2017-07-15

10.  Identification and validation of hub genes of synovial tissue for patients with osteoarthritis and rheumatoid arthritis.

Authors:  Yanzhi Ge; Zuxiang Chen; Yanbin Fu; Xiujuan Xiao; Haipeng Xu; Letian Shan; Peijian Tong; Li Zhou
Journal:  Hereditas       Date:  2021-09-28       Impact factor: 3.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.